Study of Amblyomin-X in Advanced Solid Tumor

Summary

Amblyomin-X is an inhibitor of Factor Xa that also acts as an apoptotic agent for tumor cells. In the case of in vitro assays, Amblyomin-X induces tumor cells to death and does not affect the viability of normal cells. When in vivo assays were performed on mice bearing tumors, treatment with Amblyomin-X caused a significant reduction in tumor mass and number of metastases.

Timeline

Start

2021-02-15

Primary completion

2021-08-20

Completion

2022-05-22

Outcome

Outcome not reported

Stopped: “Delay in the R \& D stage”

Drugs

Indications